AF-219
-
Merck Buying California-Based Afferent Pharmaceuticals for a Cool $1.25 Billion
Merck has entered into a $1.25 billion deal to acquire California-based Afferent Pharmaceuticals, which is developing a treatment for chronic cough,…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
